Pliant Therapeutics (PLRX) Stock Highlights

13.21 | -0.68%

2024-12-21 04:41:58

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.

Statistics

Range Today

13.07 13.85

Volume Today 1.87M

Range 1 Year

10.22 19.62

Volume 1 Year 116.71M

Range 3 Year

3.96 36.64

Volume 3 Year 478.04M

Range 10 Year

3.96 43.92

Volume 10 Year 533.77M

Highlights

Market Capitalization 923.57M (small)

Floating Shares 46.86M

Current Price 13.21

Price To Earnings -4.99

Price To Book 2.64

Earnings Per Share -3.05

Payout Ratio 0%

Performance

Latest -0.68%

1 Month +4.26%

3 Months +6.53%

6 Months +24.15%

1 Year -19.94%

3 Years -12.86%

5 Years -47.16%

10 Years -47.16%

Benchmarks

Market Capitalization

125 / 368

Gross Profits

101 / 278

Total Revenue

212 / 300

Total Rank

227 / 368

Free Cashflow

246 / 352

Performance 5 years

166 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.